Biodesix [BDSX] vs Thermo Fisher [TMO] Detailed Stock Comparison

Biodesix Inc.

NASDAQ
Loading...

Thermo Fisher Scientific Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Biodesix Inc. wins in 4 metrics, Thermo Fisher Scientific Inc. wins in 13 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Biodesix Inc. Thermo Fisher Scientific Inc. Better
P/E Ratio (TTM) N/A 25.84 N/A
Price-to-Book Ratio -34.62 3.31 Thermo Fisher Scientific Inc.
Debt-to-Equity Ratio -30.44 82.91 Thermo Fisher Scientific Inc.
PEG Ratio -47.73 2.29 Thermo Fisher Scientific Inc.
EV/EBITDA -6.98 19.02 Thermo Fisher Scientific Inc.
Profit Margin (TTM) -39.85% 15.15% Thermo Fisher Scientific Inc.
Operating Margin (TTM) -6.84% 17.89% Thermo Fisher Scientific Inc.
EBITDA Margin (TTM) N/A 17.89% N/A
Return on Equity -383.09% 13.52% Thermo Fisher Scientific Inc.
Return on Assets (TTM) -18.79% 5.00% Thermo Fisher Scientific Inc.
Free Cash Flow (TTM) $-23.67M $6.29B Thermo Fisher Scientific Inc.
Dividend Yield N/A 0.38% N/A
1-Year Return 170.20% 22.27% Biodesix Inc.
Price-to-Sales Ratio (TTM) 1.20 3.86 Biodesix Inc.
Enterprise Value $154.23M $214.76B Thermo Fisher Scientific Inc.
EV/Revenue Ratio 1.74 4.75 Biodesix Inc.
Gross Profit Margin (TTM) 83.03% N/A N/A
Revenue per Share (TTM) $12 $120 Thermo Fisher Scientific Inc.
Earnings per Share (Diluted) $-4.67 $18.18 Thermo Fisher Scientific Inc.
Beta (Stock Volatility) 0.57 0.97 Biodesix Inc.
Short % of Float 3.22% 1.22% Thermo Fisher Scientific Inc.

Biodesix Inc. vs Thermo Fisher Scientific Inc. Stock Performance Analysis

Loading Price Chart...

BDSX
TMO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Biodesix Inc.4.27%8.71%42.86%3.87%97.79%149.23%
Thermo Fisher Scientific Inc.-1.69%3.89%2.45%-6.72%-18.35%-20.01%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Biodesix Inc.170.20%-39.56%-94.00%-93.44%-93.44%-93.44%
Thermo Fisher Scientific Inc.22.27%-5.31%9.75%222.18%684.25%1,233.99%

Performance & Financial Health Analysis: Biodesix Inc. vs Thermo Fisher Scientific Inc.

MetricBDSXTMO
Market Information
Market Cap i$107.54M$174.55B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i55,3012,356,220
90 Day Avg. Volume i66,9072,071,517
Last Close$16.10$473.95
52 Week Range$5.00 - $20.21$385.46 - $643.99
% from 52W High-20.34%-26.40%
All-Time High$31.99 (Jan 18, 2021)$672.34 (Dec 27, 2021)
% from All-Time High-49.67%-29.51%
Growth Metrics
Quarterly Revenue Growth0.41%0.06%
Quarterly Earnings Growth0.41%0.10%
Financial Health
Profit Margin (TTM) i-0.40%0.15%
Operating Margin (TTM) i-0.07%0.18%
Return on Equity (TTM) i-3.83%0.14%
Debt to Equity (MRQ) i-30.4482.91
Cash & Liquidity
Book Value per Share (MRQ)$-0.30$141.96
Cash per Share (MRQ)$1.93$8.75
Operating Cash Flow (TTM) i$-23,271,000$8.29B
Levered Free Cash Flow (TTM) i$-11,825,250$5.51B
Dividends
Last 12-Month Dividend Yield iN/A0.38%
Last 12-Month Dividend iN/A$1.76

Valuation & Enterprise Metrics Analysis: Biodesix Inc. vs Thermo Fisher Scientific Inc.

MetricBDSX (Apr 26, 2026)TMO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) iN/A25.84
Forward P/E i-47.7317.16
PEG Ratio i-47.732.29
Price to Sales (TTM) i1.203.86
Price to Book (MRQ) i-34.623.31
Market Capitalization
Market Capitalization i$107.54M$174.55B
Enterprise Value i$154.23M$214.76B
Enterprise Value Metrics
Enterprise to Revenue i1.744.75
Enterprise to EBITDA i-6.9819.02
Risk & Other Metrics
Beta i0.570.97
Book Value per Share (MRQ) i$-0.30$141.96

Financial Statements Comparison: Biodesix Inc. vs Thermo Fisher Scientific Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBDSX (2025)TMO (2025)
Revenue/Sales i88.50M44.56B
Cost of Goods Sold i16.72M26.32B
COGS % of Revenue i18.9%59.1%
Gross Profit i71.78M18.24B
Gross Margin i81.1%40.9%
Research & Development i12.00M1.40B
Operating Income (EBIT) i-27.77M8.11B
Operating Margin i-31.4%18.2%
EBITDA i-21.56M11.86B
EBITDA Margin i-24.4%26.6%
Pre-Tax Income i-35.27M7.31B
Pre-Tax Income % of Revenue i-39.8%16.4%
Income Tax iN/A547.00M
Income Tax % of Revenue i0.0%1.2%
Net Income (Profit) i-35.27M6.72B
Profit Margin i-39.8%15.1%

Balance Sheet & Liquidity Metrics

MetricBDSX (2025)TMO (2025)
Cash & Equivalents i18.99M9.85B
Total Current Assets i32.52M28.71B
Total Current Assets % of Revenue i36.7%64.4%
Total Current Liabilities i17.44M15.19B
Total Current Liabilities % of Revenue i19.7%34.1%
Long-Term Debt i71.48M35.85B
Long-Term Debt % of Revenue i80.8%80.5%
Total Shareholders Equity i-2.47M53.54B
Retained Earnings i-497.76M59.16B
Retained Earnings % of Revenue i-562.4%132.8%
Property, Plant & Equipment i9.42M0

Cash Flow Statement Comparison

MetricBDSX (2025)TMO (2025)
Operating Cash Flow i-25.70M7.82B
Operating Cash Flow % of Revenue i-29.0%17.5%
Capital Expenditures i-259,000-1.48B
Free Cash Flow i-23.67M6.29B
FCF Margin i-26.8%14.1%
Debt Repayment i-21,000-3.51B
Common Stock Repurchase iN/A-3.00B

Short Interest & Institutional Ownership Analysis

MetricBDSXTMO
Shares Short i181,8184.54M
Short Ratio i1.462.38
Short % of Float i3.22%1.22%
Shares Outstanding i8.25M371.62M
Float Shares i5.95M371.07M
% Held by Insiders i43.11%0.17%
% Held by Institutions i22.21%95.23%
% Held by Public i34.68%4.60%

Dividend Analysis & Yield Comparison: Biodesix Inc. vs Thermo Fisher Scientific Inc.

MetricBDSXTMO
Last 12-Month Dividend iN/A$1.76
Last 12-Month Dividend Yield iN/A0.38%
3-Year Avg Annual Dividend iN/A$1.60
3-Year Avg Dividend Yield iN/A0.08%
3-Year Total Dividends iN/A$4.80
Ex-Dividend DateN/AMar 13, 2026